Olaparib for previously treated BRCA mutation-positive hormone-relapsed metastatic prostate cancer

Equality Impact Assessment (Guidance development) (PDF 139 KB)

Register of interests (PDF 127 KB)

Final draft guidance

Final appraisal document (PDF 368 KB)

Committee papers (PDF 466 KB)

Final appraisal document TA831 - Final Appraisal Document (PDF 353 KB)

Committee papers TA831 - Final Appraisal Document Committee papers (PDF 634 KB)

Appraisal consultation document (PDF version) TA831 - 2nd Appraisal Consultation Document (PDF 359 KB)

Committee papers TA831 - 2nd Appraisal Consultation Document Committee papers (PDF 688 KB)

Appraisal consultation document (PDF version) TA831 - 1st Appraisal Consultation Document (PDF 340 KB)

Committee papers TA831 - 1st Appraisal Consultation Document Committee papers (PDF 5.77 MB)